Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
Eric Cohen, MBA
Prior to founding Agile Capital Markets in early 2016, Eric COHEN served as CFO and executive in innovative healthcare and life science companies. His role was crucial as he managed to drive and finance the development of these companies. Eric was Teva Pharma France CFO (TEVA:NYSE) during the initiation of its generic business in France and the development of Copaxone (treatment of relapsing forms of multiple sclerosis).
Eric’s contribution was also notable within Hybrigenics (ALHYG:Euronext-Paris), a bio-pharmaceutical company with a focus on R&D of new targets and therapies against cancer, where he served as CFO and Deputy Managing Director and successfully led a private fund raising of 38 M€ and the company’s IPO on Euronext. His experience also covers medical devise business as CFO of Mauna Kea Technologies (MKEA:Euronext-Paris) pioneer in the endomicroscopy imaging, besides managing the company’s business in Germany and its global operations; Eric managed its IPO on Euronext (56 M€) and the follow-up offerings.
He currently serves as CFO of Acticor Biotech, a biotech company developing phase II treatment against acute ischemic stroke.
Eric earned a B.A and a M.A in Finance and Audit from Dauphine University in Paris and holds an MBA from London Business School.